Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases.

52W Range

14thpctl

Volume

0.70×avg

Market Cap

604.81MUSD

P/E Ratio

-4.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Altimmune, Inc.

ALTNASDAQ Global Market·USD·Closed

Altimmune, Inc.

ALTNASDAQ·USD·Closed

$3.11

−4.01%

$3.11

−$0.13 (4.01%)

52W Range

14thpctl

Volume

0.70×avg

Mkt Cap

604.81MUSD

P/E

-4.0TTM

Div Yield

–ann

ALT: Altimmune, Inc. Stock Analysis | finqOS